EU Temporarily Suspends Essure Implants

The sale and implantation of the permanent birth control device, Essure, which has led to the death of at least four women and causes pain so severe some women report becoming suicidal, has been suspended in the EU for three months pending additional information.

Read the rest…

FDA to Investigate Blood Clot Risk of Popular Birth Control Pill

By Susan Brinkmann, OCDS
Staff Journalist

The Food and Drug Administration (FDA) has announced the launching of an investigation into oral contraceptives such as Yaz and Yasmin that contain drospirenone after new research suggests these pills increase the risk of blood clots more than other oral contraceptives.

Read the rest…